In this issue, we provide information on the following topics: Important reminders on product naming Information on upcoming webinars QCP High Performers HEDIS, ONAF and other Quality information Important Clinical updates 2024 Pharmacy updates Dental information Cultural and Linguistic Requirements and Services and other administrative information And much more
Blood pressure improvements are common, with systolic pressure dropping by 5 to 10 mmHg on average
The courts approach reflects Judge Marstons experience managing large-scale GLP-1 litigation
What we know about GLP-1 medications in peri/menopausal women GLP-1 and GIP/GLP-1 receptor agonists have been extensively studied and consistently demonstrate substantial weight loss and cardiometabolic benefit in adults with overweight and obesity, including women across the adult lifespan
This exceptional result highlights its potential as one of the most effective anti-obesity therapies in development, underscoring the therapeutic promise of multi-receptor agonists in weight management
Independent Wellness focuses on transparent plan pricing, with options listed on its Pricing / Plans page